{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:45:55Z","timestamp":1787237155599,"version":"build-2736575974"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T00:00:00Z","timestamp":1744761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T00:00:00Z","timestamp":1744761600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["82DZL00401"],"award-info":[{"award-number":["82DZL00401"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["82DZL004A1"],"award-info":[{"award-number":["82DZL004A1"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["82DZL009B1"],"award-info":[{"award-number":["82DZL009B1"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["82DZL009C1"],"award-info":[{"award-number":["82DZL009C1"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["STA 1685\/1-1"],"award-info":[{"award-number":["STA 1685\/1-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Mukoviszidose e.V.","award":["S02\/09, C-H-P 1504"],"award-info":[{"award-number":["S02\/09, C-H-P 1504"]}]},{"DOI":"10.13039\/501100009318","name":"Helmholtz Association","doi-asserted-by":"publisher","award":["43.31.01"],"award-info":[{"award-number":["43.31.01"]}],"id":[{"id":"10.13039\/501100009318","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>MRI detects abnormal lung perfusion in patients with cystic fibrosis (CF). However, little is known about the contribution of bronchial arteries to lung perfusion in CF. We hypothesized that delayed perfusion can be detected by dynamic contrast-enhanced (DCE-)MRI and that\u00a0bronchial artery dilatation (BAD) is associated with changes in lung perfusion.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>Morpho-functional MRI was prospectively acquired in 75 patients with CF (18.7\u2009\u00b1\u20097.6\u2009years, range 6\u201339\u2009years). Lungs and perfusion defects were segmented automatically to quantify perfusion defects in percent (QDP). Pulmonary blood flow (PBF), mean transit time (MTT), and perfusion delay were calculated for the whole lung, inside normally perfused and perfusion defect areas. Chest MRI score and BAD were assessed visually.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      QDP and PBF correlated with MRI global score (\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u20090.58 and \u22120.53,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). In normally perfused lung, PBF was higher (161.2\u2009\u00b1\u200977.9\u2009mL\/100\u2009mL\/min vs. 57.5\u2009\u00b1\u200926.4\u2009mL\/100\u2009mL\/min,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), and MTT (5.4\u2009\u00b1\u20091.7\u2009s vs. 6.9\u2009\u00b1\u20092.3\u2009s,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) and perfusion delay were shorter than in perfusion defect areas (4.6\u2009\u00b1\u20095.3\u2009s vs.\u00a013.4\u2009\u00b1\u200916.2\u2009s,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). 48 (64.0%) patients showed BAD, had higher QDP (44.6\u2009\u00b1\u200920.8% vs. 17.3\u2009\u00b1\u200911.0%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) and lower PBF (91.9\u2009\u00b1\u200954.8\u2009mL\/100\u2009mL\/min vs. 178.3\u2009\u00b1\u200977.4\u2009mL\/100\u2009mL\/min,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) than patients without BAD. MTT was shorter (6.3\u2009\u00b1\u20091.9\u2009s vs. 8.0\u2009\u00b1\u20092.6\u2009s,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), and perfusion delay was longer (13.8\u2009\u00b1\u200910.1\u2009s vs. 12.8\u2009\u00b1\u200923.7\u2009s,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.02) inside perfusion defects of patients with BAD compared to without BAD.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Perfusion parameters correlate with lung disease severity, and perfusion defects showed delayed perfusion in patients with CF. BAD was associated with more extensive perfusion defects and reduced PBF.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Key Points<\/jats:title>\n                    <jats:p>\n                      <jats:bold>\n                        <jats:italic>Question<\/jats:italic>\n                      <\/jats:bold>\n                      <jats:italic>Dilated bronchial arteries are a common comorbidity in cystic fibrosis (CF), which can cause hemoptysis, but their quantitative contribution to lung perfusion is little researched<\/jats:italic>\n                      .\n                    <\/jats:p>\n                    <jats:p>\n                      <jats:bold>\n                        <jats:italic>Findings<\/jats:italic>\n                      <\/jats:bold>\n                      <jats:italic>Perfusion defects in percent (QDP) enabled objective assessment of perfusion abnormalities in CF patients, while perfusion delay and arterial correlation showed bronchial artery perfusion contribution<\/jats:italic>\n                      .\n                    <\/jats:p>\n                    <jats:p>\n                      <jats:bold>\n                        <jats:italic>Clinical relevance<\/jats:italic>\n                      <\/jats:bold>\n                      <jats:italic>The usage of quantitative perfusion metrics in CF may help tracking disease progression. By also including the proposed metrics perfusion delay and arterial correlation, bronchial artery inflow could be assessed and used to detect early onset of bronchial artery dilation<\/jats:italic>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical Abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1007\/s00330-025-11589-y","type":"journal-article","created":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T14:26:12Z","timestamp":1744813572000},"page":"6217-6228","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Quantitative MRI detects delayed perfusion and impact of bronchial artery dilatation on pulmonary circulation in patients with cystic fibrosis"],"prefix":"10.1007","volume":"35","author":[{"given":"Patricia","family":"Leutz-Schmidt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Grolig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Wucherpfennig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olaf","family":"Sommerburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Eichinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Wege","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon Y.","family":"Graeber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens-Peter","family":"Schenk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulsattar","family":"Alrajab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Ulrich","family":"Kauczor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjam","family":"Stahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus A.","family":"Mall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnd","family":"Koeppe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Britta","family":"Nestler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Selzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon M. F.","family":"Triphan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6962-037X","authenticated-orcid":false,"given":"Mark O.","family":"Wielp\u00fctz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,16]]},"reference":[{"key":"11589_CR1","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1164\/rccm.201910-1943SO","volume":"201","author":"MA Mall","year":"2020","unstructured":"Mall MA, Mayer-Hamblett N, Rowe SM (2020) Cystic fibrosis: emergence of highly effective targeted therapeutics and potential clinical implications. Am J Respir Crit Care Med 201:1193\u20131208. https:\/\/doi.org\/10.1164\/rccm.201910-1943SO","journal-title":"Am J Respir Crit Care Med"},{"key":"11589_CR2","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1183\/09031936.00228013","volume":"44","author":"MA Mall","year":"2014","unstructured":"Mall MA, Hartl D (2014) CFTR: cystic fibrosis and beyond. Eur Respir J 44:1042\u20131054. https:\/\/doi.org\/10.1183\/09031936.00228013","journal-title":"Eur Respir J"},{"key":"11589_CR3","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S2213-2600(19)30337-6","volume":"8","author":"SC Bell","year":"2020","unstructured":"Bell SC, Mall MA, Gutierrez H et al (2020) The future of cystic fibrosis care: a global perspective. Lancet Respir Med 8:65\u2013124. https:\/\/doi.org\/10.1016\/S2213-2600(19)30337-6","journal-title":"Lancet Respir Med"},{"key":"11589_CR4","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1164\/rccm.201002-0157OC","volume":"182","author":"PA Flume","year":"2010","unstructured":"Flume PA, Mogayzel PJ, Robinson KA et al (2010) Cystic fibrosis pulmonary guidelines: pulmonary complications: hemoptysis and pneumothorax. Am J Respir Crit Care Med 182:298\u2013306. https:\/\/doi.org\/10.1164\/rccm.201002-0157OC","journal-title":"Am J Respir Crit Care Med"},{"key":"11589_CR5","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1378\/chest.128.2.729","volume":"128","author":"PA Flume","year":"2005","unstructured":"Flume PA, Yankaskas JR, Ebeling M et al (2005) Massive hemoptysis in cystic fibrosis. Chest 128:729\u2013738. https:\/\/doi.org\/10.1378\/chest.128.2.729","journal-title":"Chest"},{"key":"11589_CR6","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1148\/rg.2018170122","volume":"38","author":"EJ Monroe","year":"2018","unstructured":"Monroe EJ, Pierce DB, Ingraham CR et al (2018) An interventionalist\u2019s guide to hemoptysis in cystic fibrosis. Radiographics 38:624\u2013641. https:\/\/doi.org\/10.1148\/rg.2018170122","journal-title":"Radiographics"},{"key":"11589_CR7","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1164\/arrd.1978.117.5.825","volume":"117","author":"RC Stern","year":"1978","unstructured":"Stern RC, Wood RE, Boat TF et al (1978) Treatment and prognosis of massive hemoptysis in cystic fibrosis. Am Rev Respir Dis 117:825\u2013828. https:\/\/doi.org\/10.1164\/arrd.1978.117.5.825","journal-title":"Am Rev Respir Dis"},{"key":"11589_CR8","doi-asserted-by":"publisher","first-page":"S39","DOI":"10.1164\/ajrccm.164.supplement_2.2106065","volume":"164","author":"DM McDonald","year":"2001","unstructured":"McDonald DM (2001) Angiogenesis and remodeling of airway vasculature in chronic inflammation. Am J Respir Crit Care Med 164:S39\u2013S45. https:\/\/doi.org\/10.1164\/ajrccm.164.supplement_2.2106065","journal-title":"Am J Respir Crit Care Med"},{"key":"11589_CR9","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1016\/j.ejrad.2011.02.045","volume":"81","author":"M Eichinger","year":"2012","unstructured":"Eichinger M, Optazaite D-E, Kopp-Schneider A et al (2012) Morphologic and functional scoring of cystic fibrosis lung disease using MRI. Eur J Radiol 81:1321\u20131329. https:\/\/doi.org\/10.1016\/j.ejrad.2011.02.045","journal-title":"Eur J Radiol"},{"key":"11589_CR10","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1164\/rccm.201309-1659OC","volume":"189","author":"MO Wielp\u00fctz","year":"2014","unstructured":"Wielp\u00fctz MO, Puderbach M, Kopp-Schneider A et al (2014) Magnetic resonance imaging detects changes in structure and perfusion, and response to therapy in early cystic fibrosis lung disease. Am J Respir Crit Care Med 189:956\u2013965. https:\/\/doi.org\/10.1164\/rccm.201309-1659OC","journal-title":"Am J Respir Crit Care Med"},{"key":"11589_CR11","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1164\/rccm.201604-0893OC","volume":"195","author":"M Stahl","year":"2017","unstructured":"Stahl M, Wielp\u00fctz MO, Graeber SY et al (2017) Comparison of lung clearance index and magnetic resonance imaging for assessment of lung disease in children with cystic fibrosis. Am J Respir Crit Care Med 195:349\u2013359. https:\/\/doi.org\/10.1164\/rccm.201604-0893OC","journal-title":"Am J Respir Crit Care Med"},{"key":"11589_CR12","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1164\/rccm.201812-2356LE","volume":"200","author":"MO Wielp\u00fctz","year":"2019","unstructured":"Wielp\u00fctz MO, Eichinger M, Wege S et al (2019) Midterm reproducibility of chest magnetic resonance imaging in adults with clinically stable cystic fibrosis and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 200:103\u2013107. https:\/\/doi.org\/10.1164\/rccm.201812-2356LE","journal-title":"Am J Respir Crit Care Med"},{"key":"11589_CR13","doi-asserted-by":"publisher","unstructured":"Leutz-Schmidt P, Optazaite D-E, Sommerburg O et al (2023) Magnetic resonance imaging detects onset and association with lung disease severity of bronchial artery dilatation in cystic fibrosis. ERJ Open Res. https:\/\/doi.org\/10.1183\/23120541.00473-2022","DOI":"10.1183\/23120541.00473-2022"},{"key":"11589_CR14","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1164\/rccm.202110-2249OC","volume":"205","author":"SY Graeber","year":"2022","unstructured":"Graeber SY, Vitzthum C, Pallenberg ST et al (2022) Effects of elexacaftor\/tezacaftor\/ivacaftor therapy on CFTR function in patients with cystic fibrosis and one or two F508del alleles. Am J Respir Crit Care Med 205:540\u2013549. https:\/\/doi.org\/10.1164\/rccm.202110-2249OC","journal-title":"Am J Respir Crit Care Med"},{"key":"11589_CR15","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/j.jcf.2022.03.011","volume":"21","author":"L Wucherpfennig","year":"2022","unstructured":"Wucherpfennig L, Triphan SMF, Wege S et al (2022) Magnetic resonance imaging detects improvements of pulmonary and paranasal sinus abnormalities in response to elexacaftor\/tezacaftor\/ivacaftor therapy in adults with cystic fibrosis. J Cyst Fibros 21:1053\u20131060. https:\/\/doi.org\/10.1016\/j.jcf.2022.03.011","journal-title":"J Cyst Fibros"},{"key":"11589_CR16","doi-asserted-by":"publisher","unstructured":"Stahl M, Dohna M, Graeber SY et al (2024) Impact of elexacaftor\/tezacaftor\/ivacaftor therapy on lung clearance index and magnetic resonance imaging in children with cystic fibrosis and one or two F508del alleles. Eur Respir J. https:\/\/doi.org\/10.1183\/13993003.00004-2024","DOI":"10.1183\/13993003.00004-2024"},{"key":"11589_CR17","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1055\/s-0042-104936","volume":"188","author":"MO Wielp\u00fctz","year":"2016","unstructured":"Wielp\u00fctz MO, Eichinger M, Biederer J et al (2016) Imaging of cystic fibrosis lung disease and clinical interpretation. Rofo 188:834\u2013845. https:\/\/doi.org\/10.1055\/s-0042-104936","journal-title":"Rofo"},{"key":"11589_CR18","doi-asserted-by":"publisher","first-page":"e230104","DOI":"10.1148\/ryct.230104","volume":"6","author":"M Dohna","year":"2024","unstructured":"Dohna M, Voskrebenzev A, Klime\u0161 F et al (2024) PREFUL MRI for monitoring perfusion and ventilation changes after elexacaftor-tezacaftor-ivacaftor therapy for cystic fibrosis: a feasibility study. Radiol Cardiothorac Imaging 6:e230104. https:\/\/doi.org\/10.1148\/ryct.230104","journal-title":"Radiol Cardiothorac Imaging"},{"key":"11589_CR19","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1513\/AnnalsATS.202302-168OC","volume":"20","author":"L Wucherpfennig","year":"2023","unstructured":"Wucherpfennig L, Triphan SMF, Wege S et al (2023) Elexacaftor\/tezacaftor\/ivacaftor improves bronchial artery dilatation detected by magnetic resonance imaging in patients with cystic fibrosis. Ann Am Thorac Soc 20:1595\u20131604. https:\/\/doi.org\/10.1513\/AnnalsATS.202302-168OC","journal-title":"Ann Am Thorac Soc"},{"key":"11589_CR20","doi-asserted-by":"publisher","unstructured":"Konietzke M, Triphan SMF, Eichinger M et al (2022) Unsupervised clustering algorithms improve the reproducibility of dynamic contrast-enhanced magnetic resonance imaging pulmonary perfusion quantification in muco-obstructive lung diseases. Front Med. https:\/\/doi.org\/10.3389\/fmed.2022.1022981","DOI":"10.3389\/fmed.2022.1022981"},{"key":"11589_CR21","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1007\/s00330-021-08229-6","volume":"32","author":"M Schiwek","year":"2022","unstructured":"Schiwek M, Triphan SMF, Biederer J et al (2022) Quantification of pulmonary perfusion abnormalities using DCE-MRI in COPD: comparison with quantitative CT and pulmonary function. Eur Radiol 32:1879\u20131890. https:\/\/doi.org\/10.1007\/s00330-021-08229-6","journal-title":"Eur Radiol"},{"key":"11589_CR22","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.ejrad.2009.07.025","volume":"77","author":"F Risse","year":"2011","unstructured":"Risse F, Eichinger M, Kauczor H-U et al (2011) Improved visualization of delayed perfusion in lung MRI. Eur J Radiol 77:105\u2013110. https:\/\/doi.org\/10.1016\/j.ejrad.2009.07.025","journal-title":"Eur J Radiol"},{"key":"11589_CR23","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1001\/jama.2012.5214","volume":"307","author":"M Rosenfeld","year":"2012","unstructured":"Rosenfeld M, Ratjen F, Brumback L et al (2012) Inhaled hypertonic saline in infants and children younger than 6 years with cystic fibrosis: the ISIS randomized controlled trial. JAMA 307:2269\u20132277. https:\/\/doi.org\/10.1001\/jama.2012.5214","journal-title":"JAMA"},{"key":"11589_CR24","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.jcf.2018.05.003","volume":"17","author":"MO Wielp\u00fctz","year":"2018","unstructured":"Wielp\u00fctz MO, von Stackelberg O, Stahl M et al (2018) Multicentre standardisation of chest MRI as radiation-free outcome measure of lung disease in young children with cystic fibrosis. J Cyst Fibros 17:518\u2013527. https:\/\/doi.org\/10.1016\/j.jcf.2018.05.003","journal-title":"J Cyst Fibros"},{"key":"11589_CR25","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1002\/jmri.27271","volume":"52","author":"SMF Triphan","year":"2020","unstructured":"Triphan SMF, Stahl M, Jobst BJ et al (2020) Echo time-dependence of observed lung T1 in patients with cystic fibrosis and correlation with clinical metrics. J Magn Reson Imaging 52:1645\u20131654. https:\/\/doi.org\/10.1002\/jmri.27271","journal-title":"J Magn Reson Imaging"},{"key":"11589_CR26","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s11548-014-1090-0","volume":"10","author":"P Kohlmann","year":"2015","unstructured":"Kohlmann P, Strehlow J, Jobst B et al (2015) Automatic lung segmentation method for MRI-based lung perfusion studies of patients with chronic obstructive pulmonary disease. Int J Comput Assist Radiol Surg 10:403\u2013417. https:\/\/doi.org\/10.1007\/s11548-014-1090-0","journal-title":"Int J Comput Assist Radiol Surg"},{"key":"11589_CR27","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1109\/TMI.2009.2035616","volume":"29","author":"S Klein","year":"2010","unstructured":"Klein S, Staring M, Murphy K et al (2010) elastix: a toolbox for intensity-based medical image registration. IEEE Trans Med Imaging 29:196\u2013205. https:\/\/doi.org\/10.1109\/TMI.2009.2035616","journal-title":"IEEE Trans Med Imaging"},{"key":"11589_CR28","doi-asserted-by":"publisher","unstructured":"Shamonin DP, Bron EE, Lelieveldt BPF et al (2014) Fast parallel image registration on CPU and GPU for diagnostic classification of Alzheimer\u2019s disease. Front Neuroinform. https:\/\/doi.org\/10.3389\/fninf.2013.00050","DOI":"10.3389\/fninf.2013.00050"},{"key":"11589_CR29","doi-asserted-by":"publisher","first-page":"1184784","DOI":"10.3389\/fmed.2023.1184784","volume":"10","author":"P Konietzke","year":"2023","unstructured":"Konietzke P, Brunner C, Konietzke M et al (2023) GOLD stage-specific phenotyping of emphysema and airway disease using quantitative computed tomography. Front Med 10:1184784. https:\/\/doi.org\/10.3389\/fmed.2023.1184784","journal-title":"Front Med"},{"key":"11589_CR30","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1175\/MWR3133.1","volume":"134","author":"K-M Xu","year":"2006","unstructured":"Xu K-M (2006) Using the Bootstrap method for a statistical significance test of differences between summary histograms. Monthly Weather Rev 134:1442\u20131453. https:\/\/doi.org\/10.1175\/MWR3133.1","journal-title":"Monthly Weather Rev"},{"key":"11589_CR31","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12968-016-0252-3","volume":"18","author":"T Wehrum","year":"2016","unstructured":"Wehrum T, Hagenlocher P, Lodemann T et al (2016) Age dependence of pulmonary artery blood flow measured by 4D flow cardiovascular magnetic resonance: results of a population-based study. J Cardiovasc Magn Reson 18:31. https:\/\/doi.org\/10.1186\/s12968-016-0252-3","journal-title":"J Cardiovasc Magn Reson"},{"key":"11589_CR32","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1152\/japplphysiol.00512.2006","volume":"102","author":"DL Levin","year":"2007","unstructured":"Levin DL, Buxton RB, Spiess JP et al (2007) Effects of age on pulmonary perfusion heterogeneity measured by magnetic resonance imaging. J Appl Physiol (1985) 102:2064\u20132070. https:\/\/doi.org\/10.1152\/japplphysiol.00512.2006","journal-title":"J Appl Physiol (1985)"},{"key":"11589_CR33","doi-asserted-by":"publisher","first-page":"878","DOI":"10.2214\/AJR.07.2833","volume":"190","author":"CA Yi","year":"2008","unstructured":"Yi CA, Lee KS, Han J et al (2008) 3-T MRI for differentiating inflammation- and fibrosis-predominant lesions of usual and nonspecific interstitial pneumonia: comparison study with pathologic correlation. AJR Am J Roentgenol 190:878\u2013885. https:\/\/doi.org\/10.2214\/AJR.07.2833","journal-title":"AJR Am J Roentgenol"},{"key":"11589_CR34","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s10334-024-01151-0","volume":"37","author":"M Parillo","year":"2024","unstructured":"Parillo M, Mallio CA, Dekkers IA et al (2024) Late\/delayed gadolinium enhancement in MRI after intravenous administration of extracellular gadolinium-based contrast agents: is it worth waiting?. MAGMA 37:151\u2013168. https:\/\/doi.org\/10.1007\/s10334-024-01151-0","journal-title":"MAGMA"},{"key":"11589_CR35","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1055\/s-2008-1032468","volume":"160","author":"HC Schwickert","year":"1994","unstructured":"Schwickert HC, Kauczor H-U, Schweden F, Schild HH (1994) Anatomie der bronchialarterien\u2014darstellung mit der spiral-CT. Rofo 160:506\u2013512. https:\/\/doi.org\/10.1055\/s-2008-1032468","journal-title":"Rofo"},{"key":"11589_CR36","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1152\/japplphysiol.00320.2012","volume":"113","author":"SR Hopkins","year":"2012","unstructured":"Hopkins SR, Wielp\u00fctz MO, Kauczor H-U (2012) Imaging lung perfusion. J Appl Physiol (1985) 113:328\u2013339. https:\/\/doi.org\/10.1152\/japplphysiol.00320.2012","journal-title":"J Appl Physiol (1985)"},{"key":"11589_CR37","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1378\/chest.62.4.447","volume":"62","author":"KK Pump","year":"1972","unstructured":"Pump KK (1972) Distribution of bronchial arteries in the human lung. Chest 62:447\u2013451. https:\/\/doi.org\/10.1378\/chest.62.4.447","journal-title":"Chest"},{"key":"11589_CR38","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/BF02337825","volume":"11","author":"M Viamonte","year":"1989","unstructured":"Viamonte M, Viamonte M, Camacho M, Liebow AA (1989) Corrosion cast studies of the bronchial arteries. Surg Radiol Anat 11:215\u2013219. https:\/\/doi.org\/10.1007\/BF02337825","journal-title":"Surg Radiol Anat"},{"key":"11589_CR39","doi-asserted-by":"publisher","first-page":"578","DOI":"10.3109\/02841859909175591","volume":"40","author":"I Hasegawa","year":"1999","unstructured":"Hasegawa I, Kobayashi K, Kohda E, Hiramatsu K (1999) Bronchopulmonary arterial anastomosis at the precapillary level in human lung. Visualization using CT angiography compared with microangiography of autopsied lung. Acta Radiol 40:578\u2013584. https:\/\/doi.org\/10.3109\/02841859909175591","journal-title":"Acta Radiol"},{"key":"11589_CR40","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1016\/j.jcf.2022.04.015","volume":"21","author":"P Habert","year":"2022","unstructured":"Habert P, Puech B, Coiffard B et al (2022) Angiographic and histopathological study on bronchial-to-pulmonary vascular anastomoses on explants from patients with cystic fibrosis after bronchial artery embolisation. J Cyst Fibros 21:1042\u20131047. https:\/\/doi.org\/10.1016\/j.jcf.2022.04.015","journal-title":"J Cyst Fibros"},{"key":"11589_CR41","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1007\/s00330-005-2721-1","volume":"15","author":"S Ley","year":"2005","unstructured":"Ley S, Puderbach M, Fink C et al (2005) Assessment of hemodynamic changes in the systemic and pulmonary arterial circulation in patients with cystic fibrosis using phase-contrast MRI. Eur Radiol 15:1575\u20131580. https:\/\/doi.org\/10.1007\/s00330-005-2721-1","journal-title":"Eur Radiol"},{"key":"11589_CR42","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.2214\/ajr.179.5.1791209","volume":"179","author":"S Ley","year":"2002","unstructured":"Ley S, Kreitner K-F, Morgenstern I et al (2002) Bronchopulmonary shunts in patients with chronic thromboembolic pulmonary hypertension: evaluation with helical CT and MR imaging. AJR Am J Roentgenol 179:1209\u20131215. https:\/\/doi.org\/10.2214\/ajr.179.5.1791209","journal-title":"AJR Am J Roentgenol"},{"key":"11589_CR43","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1164\/arrd.1987.135.2.463","volume":"135","author":"ME Deffebach","year":"1987","unstructured":"Deffebach ME, Charan NB, Lakshminarayan S, Butler J (1987) The bronchial circulation. Small, but a vital attribute of the lung. Am Rev Respir Dis 135:463\u2013481. https:\/\/doi.org\/10.1164\/arrd.1987.135.2.463","journal-title":"Am Rev Respir Dis"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-025-11589-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-025-11589-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-025-11589-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T10:02:59Z","timestamp":1757498579000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-025-11589-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,16]]},"references-count":43,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["11589"],"URL":"https:\/\/doi.org\/10.1007\/s00330-025-11589-y","relation":{},"ISSN":["1432-1084"],"issn-type":[{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,16]]},"assertion":[{"value":"3 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The scientific guarantor of this publication is Mark O. Wielp\u00fctz.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"The authors of this manuscript declare relationships with the following companies: M.O.W.: Vertex Pharmaceuticals: Participation in clinical intervention trials with payment to the institution during the last 36 months. Honoraria for lectures from Vertex Pharmaceuticals paid to the institution. Boehringer Ingelheim: Study grants and honoraria for lectures paid to the institution. O.S.: Vertex Pharmaceuticals: Participation in 6 official clinical intervention trials with regular payment to the institution during the last 36 months. Honoraria for lectures of approximately (but not more than) 10,000 \u20ac during the last 36 months. M.E.: Vertex Pharmaceuticals: Honoraria for lectures from Vertex Pharmaceuticals. S.Y.G.: Vertex Pharmaceuticals: Personal fees for presentations and for advisory board. Grant payments made to the institution. Mukoviszidose Institut gGmbH, Bonn (German CF Foundation): Grants or contracts, payments made to the institution. H.U.K.: Siemens: Research support, payments to the institution. M.St.: Vertex Pharmaceuticals: Independent RIA grant (payment to institution), various clinical studies (payment to institution), honoraria for lectures and personal fees for advisory board. M.A.M.: Vertex Pharmaceuticals: Payments to the institution for independent medical grant. Personal fees for consultancy, lectures, travel reimbursement and advisory board membership. Boehringer Ingelheim: Personal fees for consultancy, lectures, travel reimbursement and advisory board membership. Arrowhead Pharmaceuticals: Personal fees for consultancy, lectures and advisory board membership. Santhera: Personal fees for consultancy and advisory board membership. Sterna Biologicals: Personal fees for consultancy. Enterprise Therapeutics: Personal fees for consultancy and advisory board membership. Kither Biotech: Personal fees for consultancy and advisory board membership. Antabio: Personal fees for consultancy and advisory board membership.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No complex statistical methods were necessary for this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Written informed consent was obtained from all patients or their parents or legal guardians.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"This study is part of an ongoing prospective observational study (clinicaltrials.gov identifiers NCT00760071, NCT02270476 and DRKS00031784) and was approved by the responsible ethics committee of the coordinating center (Institutional review board of the University of Heidelberg, Germany).","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The study subjects have been previously reported in the following two publications: [\n                      \n                      ,\n                      \n                      ]. However, the quantitative analysis of the perfusion measurements proposed in this study was never performed before.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Study subjects or cohorts overlap"}},{"order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}